More Than 200 Companies Accelerate Clinical Trials Management Using Veeva's CTMS

In a significant industry advancement, Veeva Systems (NYSE: VEEV) recently announced that over 200 companies, including 17 of the 20 largest biopharmaceutical firms, are utilizing its Clinical Trial Management System (CTMS) to conduct more efficient and effective clinical trials. Given the increasing complexity of studies and rising data volumes, biopharmaceuticals and contract research organizations are leveraging Veeva's CTMS to centralize data and documentation, streamlining their processes for better collaboration among stakeholders.

Bonne Adams, Vice President of Operations at Inhibrx, shared, “The CTMS from Veeva is pivotal for our trials, allowing for seamless flow of study metrics and documents throughout our ecosystem.” She noted that using clinical apps on a connected platform enables their smaller team to save time and efforts while enhancing their collaboration with partner contract research organizations.

Whether biopharmaceutical companies conduct trials in-house or outsource them, Veeva's CTMS allows clinical teams to proactively manage studies. They can swiftly identify and resolve issues, thanks to the platform's flexible and scalable nature. This agility not only accelerates trial execution but also ensures the provision of high-quality data that complies with international regulations like ICH E6(R2) and (R3).

As the clinical trial model evolves and regulations change, Veeva remains dedicated to delivering continual innovation. Recent enhancements to the CTMS include:

- Automated daily data transfers between contract research organizations and sponsors for improved visibility.
- Problem tracking and management for faster resolutions.
- Upgrades to streamline the management of internal, outsourced, and complex trials to foster speed and agility.

Henry Galio, Vice President of CTMS Strategy at Veeva, emphasized, “Modern CTMS must be scalable and support both internal and external operational models.” To provide this flexibility, Veeva introduces new CTMS features three times a year, continuously working to enhance collaboration within the industry and expedite execution.

This growing adoption of Veeva's CTMS reflects a trend where more companies simplify trial processes while maintaining compliance, regardless of their operational model. Veeva's CTMS is part of the company's clinical platform, recognized as the most comprehensive and highest quality system for faster and more effective trials. For professionals in the life sciences industry, there is an upcoming opportunity to learn more at the Veeva R&D and Quality Summit in Europe scheduled for June 4-5 in Madrid. Interested professionals can register for the event.

For further information on the CTMS, visit veeva.com/eu/CTMS. Connect with Veeva on LinkedIn to stay updated on their latest innovations and industry insights.

About Veeva Systems: Established as the global leader in cloud software for the life sciences sector, Veeva is committed to product excellence and customer success, serving over 1,000 customers from large biopharmaceutical companies to emerging biotechnology firms. Veeva aims to align diverse stakeholder interests, including clients, employees, shareholders, and the industries they support. For more information, visit veeva.com/eu.